NBY vs PTC · $51.9M cap vs P/E 48, rev $2.74B
NovaBay Pharmaceuticals Inc (NBY) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
NBY does not have a complete income-statement cache yet.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
NBY currently screens at market cap $51.9M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the NBY and PTC stock pages for the full models.
Not investment advice.